HEADER RIBOSOMAL PROTEIN 30-MAR-11 2LBF TITLE SOLUTION STRUCTURE OF THE DIMERIZATION DOMAIN OF HUMAN RIBOSOMAL TITLE 2 PROTEIN P1/P2 HETERODIMER COMPND MOL_ID: 1; COMPND 2 MOLECULE: 60S ACIDIC RIBOSOMAL PROTEIN P1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 1-69; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: 60S ACIDIC RIBOSOMAL PROTEIN P2; COMPND 8 CHAIN: B; COMPND 9 FRAGMENT: UNP RESIDUES 1-69; COMPND 10 SYNONYM: RENAL CARCINOMA ANTIGEN NY-REN-44; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: RPLP1, RRP1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: VECTOR; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET3D; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 GENE: RPLP2, D11S2243E, RPP2; SOURCE 15 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 16 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: VECTOR; SOURCE 18 EXPRESSION_SYSTEM_VECTOR: PRSETA KEYWDS RIBOSOME, STALK, P1/P2, RIBOSOMAL PROTEIN EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR K.-M.LEE,C.W.-H.YU,T.Y.-H.CHIU,K.-H.SZE,P.-C.SHAW,K.-B.WONG REVDAT 2 14-JUN-23 2LBF 1 REMARK SEQADV REVDAT 1 14-DEC-11 2LBF 0 JRNL AUTH K.-M.LEE,C.W.-H.YU,T.Y.-H.CHIU,K.-H.SZE,P.-C.SHAW,K.-B.WONG JRNL TITL SOLUTION STRUCTURE OF THE DIMERIZATION DOMAIN OF THE JRNL TITL 2 EUKARYOTIC STALK P1/P2 COMPLEX REVEALS THE STRUCTURAL JRNL TITL 3 ORGANIZATION OF EUKARYOTIC STALK COMPLEX JRNL REF NUCLEIC ACIDS RES. 2011 JRNL REFN ESSN 1362-4962 JRNL PMID 22135285 JRNL DOI 10.1093/NAR/GKR1143 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : ARIA, CNS REMARK 3 AUTHORS : LINGE, O'DONOGHUE AND NILGES (ARIA), REMARK 3 BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-KUNSTLEVE,JIANG,KUSZEWSKI, REMARK 3 NILGES, PANNU,READ,RICE,SIMONSON,WARREN (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2LBF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 12-APR-11. REMARK 100 THE DEPOSITION ID IS D_1000102190. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : 0.15 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1 MM [U-100% 13C; U-100% 15N] REMARK 210 PROTEIN_1-1, 1 MM [U-100% 13C; U- REMARK 210 100% 15N] PROTEIN_2-2, 90% H2O/ REMARK 210 10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : ARIA REMARK 210 METHOD USED : DGSA-DISTANCE GEOMETRY SIMULATED REMARK 210 ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HB VAL A 37 HA3 GLY B 113 1.25 REMARK 500 HB2 TYR B 103 HG12 VAL B 142 1.27 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ALA A 2 -167.59 -115.83 REMARK 500 1 ASN A 53 -41.71 -143.01 REMARK 500 1 ASN A 62 59.81 35.25 REMARK 500 1 VAL A 63 43.70 34.19 REMARK 500 1 ARG B 102 -162.84 79.36 REMARK 500 1 SER B 117 68.88 -168.01 REMARK 500 1 LEU B 162 116.82 -38.08 REMARK 500 1 ALA B 163 -78.29 46.39 REMARK 500 1 PRO B 166 115.74 -16.99 REMARK 500 2 LEU A 51 45.47 -74.21 REMARK 500 2 VAL A 63 32.67 -80.23 REMARK 500 2 ARG B 102 -92.15 -152.99 REMARK 500 2 SER B 116 26.80 -77.04 REMARK 500 2 SER B 117 70.39 -168.80 REMARK 500 2 LEU B 162 123.39 -29.12 REMARK 500 2 ALA B 163 -68.58 61.05 REMARK 500 2 PRO B 166 116.44 -12.51 REMARK 500 3 ALA A 2 149.38 176.35 REMARK 500 3 ASN A 53 -48.20 -143.62 REMARK 500 3 ASN A 62 -13.83 54.53 REMARK 500 3 VAL A 63 34.62 -82.60 REMARK 500 3 ARG B 102 125.90 -170.02 REMARK 500 3 TYR B 103 -25.66 71.66 REMARK 500 3 SER B 116 26.01 -79.97 REMARK 500 3 SER B 117 69.82 -172.31 REMARK 500 3 ILE B 155 44.10 -109.15 REMARK 500 3 LEU B 162 -162.70 45.03 REMARK 500 3 ALA B 163 -90.85 50.56 REMARK 500 3 PRO B 166 110.65 -17.10 REMARK 500 4 ASN A 53 -52.80 -139.52 REMARK 500 4 ARG B 102 -91.12 -172.52 REMARK 500 4 SER B 116 31.09 -80.23 REMARK 500 4 SER B 117 67.64 -171.00 REMARK 500 4 GLN B 157 -34.83 -137.36 REMARK 500 4 SER B 164 159.13 62.43 REMARK 500 4 PRO B 166 121.13 -13.70 REMARK 500 5 THR A 22 127.97 -34.96 REMARK 500 5 LEU A 51 0.77 -66.90 REMARK 500 5 ASN A 53 -38.26 -130.69 REMARK 500 5 PRO A 68 38.63 -86.55 REMARK 500 5 ARG B 102 -147.26 -170.24 REMARK 500 5 SER B 116 25.61 -76.96 REMARK 500 5 SER B 117 68.12 -169.83 REMARK 500 5 GLN B 157 16.08 -142.05 REMARK 500 5 LEU B 162 175.88 48.27 REMARK 500 5 ALA B 163 -88.57 55.13 REMARK 500 5 PRO B 166 114.85 -19.63 REMARK 500 6 ARG B 102 -122.74 -162.74 REMARK 500 6 SER B 117 67.96 -175.78 REMARK 500 6 SER B 164 169.49 56.90 REMARK 500 REMARK 500 THIS ENTRY HAS 85 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 17557 RELATED DB: BMRB DBREF 2LBF A 1 69 UNP P05386 RLA1_HUMAN 1 69 DBREF 2LBF B 101 169 UNP P05387 RLA2_HUMAN 1 69 SEQADV 2LBF ALA B 100 UNP P05387 EXPRESSION TAG SEQRES 1 A 69 MET ALA SER VAL SER GLU LEU ALA CYS ILE TYR SER ALA SEQRES 2 A 69 LEU ILE LEU HIS ASP ASP GLU VAL THR VAL THR GLU ASP SEQRES 3 A 69 LYS ILE ASN ALA LEU ILE LYS ALA ALA GLY VAL ASN VAL SEQRES 4 A 69 GLU PRO PHE TRP PRO GLY LEU PHE ALA LYS ALA LEU ALA SEQRES 5 A 69 ASN VAL ASN ILE GLY SER LEU ILE CYS ASN VAL GLY ALA SEQRES 6 A 69 GLY GLY PRO ALA SEQRES 1 B 70 ALA MET ARG TYR VAL ALA SER TYR LEU LEU ALA ALA LEU SEQRES 2 B 70 GLY GLY ASN SER SER PRO SER ALA LYS ASP ILE LYS LYS SEQRES 3 B 70 ILE LEU ASP SER VAL GLY ILE GLU ALA ASP ASP ASP ARG SEQRES 4 B 70 LEU ASN LYS VAL ILE SER GLU LEU ASN GLY LYS ASN ILE SEQRES 5 B 70 GLU ASP VAL ILE ALA GLN GLY ILE GLY LYS LEU ALA SER SEQRES 6 B 70 VAL PRO ALA GLY GLY HELIX 1 1 SER A 3 GLU A 20 1 18 HELIX 2 2 THR A 24 GLY A 36 1 13 HELIX 3 3 PRO A 41 LEU A 51 1 11 HELIX 4 4 ASN A 55 CYS A 61 5 7 HELIX 5 5 TYR B 103 GLY B 114 1 12 HELIX 6 6 SER B 119 SER B 129 1 11 HELIX 7 7 ASP B 137 ASN B 147 1 11 HELIX 8 8 ASN B 150 ALA B 156 1 7 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1